Published in Circulation on January 04, 2000
Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians. J Gen Intern Med (2003) 2.22
Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res (2010) 1.45
Common carotid artery wall thickness and external diameter as predictors of prevalent and incident cardiac events in a large population study. Cardiovasc Ultrasound (2007) 1.12
Distribution of 10-year and lifetime predicted risk for cardiovascular disease in the Indian Sentinel Surveillance Study population (cross-sectional survey results). BMJ Open (2011) 1.07
Association of 10-year and lifetime predicted cardiovascular disease risk with subclinical atherosclerosis in South Asians: findings from the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study. J Am Heart Assoc (2014) 0.85
Metabolic syndrome & Framingham Risk Score: observations from a coronary angiographic study in Indian patients. Indian J Med Res (2013) 0.84
Context and cardiovascular risk modification in two regions of Ontario, Canada: a photo elicitation study. Int J Environ Res Public Health (2009) 0.82
Cross-sectional epidemiological study to evaluate the cardiovascular profile of a cohort of blood donors. Blood Transfus (2007) 0.81
Subnormal Estimated Glomerular Filtration Rate Strongly Predict Incident Cardiovascular Events in Type 2 Diabetic Chinese Population With Normoalbuminuria. Medicine (Baltimore) (2016) 0.78
Lipid profile in children with coronary artery disease in Sindh, Pakistan. World J Cardiol (2014) 0.77
Lifestyle factors, body mass index, and lipid profile in adolescents. J Pediatr Psychol (2007) 0.75
The impact of age & ethnicity in coronary artery disease risk assessment using Framingham Risk Scores & metabolic syndrome. Indian J Med Res (2013) 0.75
Metabolic Syndrome and Framingham Risk Score: Observation from Screening of Low-Income Semi-Urban African Women. Medicines (Basel) (2016) 0.75
[Clinical outcomes, health-related quality of life, and cost-effectiveness of a 6-month community- based lifestyle program for adults at increased cardiovascular risk in lower Austria]. Wien Med Wochenschr (2012) 0.75
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
Cardiovascular disease risk profiles. Am Heart J (1991) 21.65
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med (1990) 17.52
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA (2000) 12.27
Diabetes and cardiovascular disease. The Framingham study. JAMA (1979) 11.95
An updated coronary risk profile. A statement for health professionals. Circulation (1991) 11.71
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
The Framingham Offspring Study. Design and preliminary data. Prev Med (1975) 10.53
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med (1982) 8.62
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09
Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1999) 8.04
The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01
Human blood pressure determination by sphygmomanometry. Circulation (1993) 7.88
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med (1971) 7.46
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA (1986) 7.23
Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med (1990) 7.00
Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72
Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med (1999) 6.62
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol (1997) 6.10
Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J (1986) 5.89
Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA (1997) 5.85
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke (1994) 5.83
Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med (2001) 5.68
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation (1999) 5.62
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes (1974) 5.55
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54
Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA (2001) 5.54
Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med (2001) 5.43
Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation (2000) 5.41
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology (1978) 5.37
Diabetes and cardiovascular risk factors: the Framingham study. Circulation (1979) 5.32
Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA (2000) 5.31
Racial differences in the use of cardiac catheterization after acute myocardial infarction. N Engl J Med (2001) 5.29
Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol (1974) 5.11
Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation (2001) 5.11
A general cardiovascular risk profile: the Framingham Study. Am J Cardiol (1976) 5.10
Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation (2001) 5.08
Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol (1972) 5.05
Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann Intern Med (2001) 5.05
Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med (1984) 5.02
Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med (1979) 4.94
Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. J Am Coll Cardiol (1996) 4.92
Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol (1971) 4.90
The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol (2000) 4.77
Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med (1994) 4.74
Some health benefits of physical activity. The Framingham Study. Arch Intern Med (1979) 4.63
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clin Pharmacol Ther (2008) 4.54
Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA (1998) 4.38
Social desirability bias in dietary self-report may compromise the validity of dietary intake measures. Int J Epidemiol (1995) 4.36
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36
Do "America's Best Hospitals" perform better for acute myocardial infarction? N Engl J Med (1999) 4.30
Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med (1993) 4.30
A predictive instrument to improve coronary-care-unit admission practices in acute ischemic heart disease. A prospective multicenter clinical trial. N Engl J Med (1984) 4.29
The epidemiology of gallbladder disease: observations in the Framingham Study. J Chronic Dis (1966) 4.15
Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J (1987) 4.12
Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med (1970) 4.11
Stroke severity in atrial fibrillation. The Framingham Study. Stroke (1996) 4.11
Linkage of adult alpha- and beta-globin genes in X. laevis and gene duplication by tetraploidization. Cell (1980) 4.09
Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation (1995) 4.04
Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J (1994) 4.02
Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med (1990) 3.99
The Behavior Change Consortium: setting the stage for a new century of health behavior-change research. Health Educ Res (2002) 3.97
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis (2000) 3.81
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med (1998) 3.79
Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care (1980) 3.70
Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study. Circulation (2001) 3.64
Variability of body weight and health outcomes in the Framingham population. N Engl J Med (1991) 3.61
Tracking of blood lipids and blood pressures in school age children: the Muscatine study. Circulation (1978) 3.59
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
Studies on ovulation: IV. Induction of ovulation in the hypophysectomized rabbit by administration of anterior lobe extracts. J Physiol (1931) 3.58
Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project. JAMA (1995) 3.56
The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell (1990) 3.56
Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology (1999) 3.55
Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med (1976) 3.50
Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature (1990) 3.48
Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest (1995) 3.44
Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? JAMA (1993) 3.42